...
首页> 外文期刊>BMC Cancer >Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis
【24h】

Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis

机译:使用窘迫温度计筛查原发性脑肿瘤患者的窘迫:系统评价和荟萃分析

获取原文
           

摘要

Patients with primary brain tumors are reported to have an elevated level of distress prevalence, due to the functional sequelae and the unfavorable prognosis, but the estimated prevalence of this disorder varies among studies. The Distress Thermometer (DT) is widely used distress screening tools to identify patients suffering from elevated psychosocial distress. The objective of this meta-analysis is to get a summarized estimate of distress prevalence in adult primary brain tumor patients screened by the DT instrument to identify distress in brain tumor patients. We searched studies published in PubMed, PsycINFO, and Cochrane library through August 2017 and checked related reviews and meta-analyses for eligible studies. Studies were eligible if they were published in the peer-reviewed literature and evaluated distress level by Distress Thermometer. The prevalence of distress symptoms in patients with the intracranial tumor was estimated by study-level characteristics using stratified meta-analysis. The prevalence of distress level or symptoms during the follow-up examination at different time points was detected by secondary analysis of the longitudinal studies included. Twelve studies including a total of 2145 brain tumor patients were included in this analysis. Eight used a cross-sectional design and four were longitudinal. The pooled prevalence of distress was 38.2% (95% confidence interval (CI) 28.7%–47.7%) for the overall sample. The pooled prevalence of distress DT ≥4 was 41.1% (642/1686, 95% CI 28.6%–53.5%) and the pooled prevalence of distress by DT ≥6 was 29.7% (137/459, 95% CI 19.5%–39.9%). The distress symptom did not decrease in follow-up studies (Relative Increase Ratio:1.02, 95% CI, (0.78, 1.35)). A huge heterogeneity in different studies was detected, and different screening scales were not compared. The high prevalence of distress becomes an enormous challenge for primary brain tumor patients. Routine screening and evaluation of distress in brain tumor patients may assist medical workers to develop proper interventions, which may lead to better quality of life and oncology management.
机译:据报道,由于功能性后遗症和预后不良,原发性脑肿瘤患者的窘迫患病率升高,但该疾病的患病率估计因研究而异。遇险温度计(DT)是广泛使用的遇险筛查工具,用于识别患有严重社会心理困扰的患者。这项荟萃分析的目的是通过DT仪器筛选出的成人原发性脑肿瘤患者的患病率汇总估计值,以识别脑肿瘤患者的患病情况。我们搜索了截至2017年8月在PubMed,PsycINFO和Cochrane图书馆中发表的研究,并检查了相关评论和荟萃分析以寻找合格的研究。如果研究发表在同行评审的文献中,并且通过遇险温度计评估了遇险水平,则该研究合格。使用分层荟萃分析,通过研究水平特征评估颅内肿瘤患者的窘迫症状患病率。通过对所包括的纵向研究的二级分析,在不同时间点的随访检查中发现了患病水平或症状的患病率。该分析包括十二项研究,包括总共2145名脑肿瘤患者。八个采用横截面设计,四个为纵向。总体样本的遇险总患病率为38.2%(95%置信区间(CI)28.7%–47.7%)。 DT≥4的合并遇险患病率为41.1%(642/1686,95%CI 28.6%–53.5%),DT≥6的合并遇险患病率为29.7%(137/459,95%CI 19.5%–39.9 %)。在后续研究中,苦恼症状没有减少(相对增加比率:1.02,95%CI,(0.78,1.35))。在不同的研究中发现了巨大的异质性,并且没有比较不同的筛查规模。对于原发性脑肿瘤患者,高患病率成为巨大的挑战。例行筛查和评估脑肿瘤患者的病情可能有助于医务人员制定适当的干预措施,从而可能改善生活质量和肿瘤治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号